Hsueh Po-Ren, Liu Cheng-Yi, Luh Kwen-Tay
National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Emerg Infect Dis. 2002 Feb;8(2):132-7. doi: 10.3201/eid0802.010244.
While some trends in antimicrobial resistance rates are universal, others appear to be unique for specific regions. In Taiwan, the strikingly high prevalence of resistance to macrolides and streptogramin in clinical isolates of gram-positive bacteria correlates with the widespread use of these agents in the medical and farming communities, respectively. The relatively low rate of enterococci that are resistant to glycopeptide does not parallel the high use of glycopeptides and extended-spectrum beta-lactams in hospitals. The evolving problem of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates is substantial, and some unique enzymes have been found. Recently, some gram-negative bacteria (e.g., Pseudomonas aeruginosa and Acinetobacter baumannii) that are resistant to all available antimicrobial agents including carbapenems have emerged.
虽然抗菌药物耐药率的一些趋势是普遍存在的,但其他趋势似乎在特定地区是独特的。在台湾,革兰氏阳性菌临床分离株对大环内酯类和链阳菌素的耐药率极高,分别与这些药物在医疗和农业社区的广泛使用有关。肠球菌对糖肽类耐药率相对较低,这与医院中糖肽类和广谱β-内酰胺类药物的高使用量并不相符。产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌分离株的问题日益严重,并且已经发现了一些独特的酶。最近,出现了一些对包括碳青霉烯类在内的所有可用抗菌药物均耐药的革兰氏阴性菌(如铜绿假单胞菌和鲍曼不动杆菌)。